Morgan Stanley’s FitLife Brands FTLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1K Sell
1,008
-891
-47% -$8.99K ﹤0.01% 7015
2026
Q1
$27K Sell
1,899
-2,479
-57% -$37.1K ﹤0.01% 6625
2025
Q4
$71.2K Buy
4,378
+1,232
+39% +$22.6K ﹤0.01% 6315
2025
Q3
$62.6K Sell
3,146
-1,841
-37% -$29.6K ﹤0.01% 6326
2025
Q2
$64.9K Buy
4,987
+3,615
+263% +$49.7K ﹤0.01% 6272
2025
Q1
$16.6K Buy
1,372
+590
+75% +$8.77K ﹤0.01% 6636
2024
Q4
$12.7K Buy
+782
New +$12.7K ﹤0.01% 6718

Other funds holding FTLF

Morgan Stanley's FTLF Position: Q2 2026 in Review

Morgan Stanley reduced its FitLife Brands (FTLF) stake by 47% in Q2 2026, selling an estimated $8.99K and leaving 1,008 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #7015.

Morgan Stanley first reported a position in FTLF in Q4 2024 and has held it in 7 quarters since. The position peaked at $71.2K in Q4 2025. 42 funds tracked by Wall St. Rank hold FTLF as of Q2 2026.

  • Morgan Stanley held 1,008 shares of FitLife Brands worth $11.1K as of Q2 2026.
  • Morgan Stanley sold 891 FitLife Brands shares in Q2 2026, an estimated $8.99K.
  • FitLife Brands made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7015 holding.
  • Morgan Stanley first reported a position in FitLife Brands in Q4 2024 and has held it in 7 quarters since.
  • Morgan Stanley's FitLife Brands position peaked at $71.2K in Q4 2025.
  • 42 funds tracked by Wall St. Rank held FitLife Brands as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.